Format

Send to

Choose Destination
Blood Adv. 2018 Nov 13;2(21):2811-2813. doi: 10.1182/bloodadvances.2018025197.

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow.

Author information

1
Institut Universitaire du Cancer-Oncopole and Centre de Recherches en Cancérologie de Toulouse INSERM U1037, Toulouse, France.
2
Hematology Department, University Hospital, Nancy, France.
3
Hematology Department, University Hospital, Dijon, France.
4
Hematology Department, University Hospital, Poitiers, France.
5
Hematology Department, University Hospital, Bordeaux, France; and.
6
Hematology Department, University Hospital, Lille, France.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center